Vacutainers and Primers Over X-Rays and Gamma Rays: The Role of Circulating Tumor DNA in Esophageal Adenocarcinoma Staging and Surveillance: Invited Commentary on "Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma". Issue 2 (6th August 2022)